InterMune (NASDAQ:ITMN) more than doubled Tuesday to its highest value since May 2011 after saying data from a phase 3 trial showed its Pirfenidone drug significantly reduced the progression of idiopathic pulmonary fibrosis. Near midday, ITMN had jumped 126.6% at $31.63 per share in recent trading. Earlier it hit $37.22. Also, significant treatment effects were…
Home Depot (NYSE:HD) reported Q4 sales shy of expectations Tuesday morning while also beating on EPS and hiking its dividend. Home Depot has just favored a long-term reversal pattern between the sessions, cutting back or reversing course in the following regular sessions after 20 of the last 36 pre-market earnings events we’ve tracked. Looking deeper…
China Unicom reported nine-month results that continue to show strong revenue growth, but at the expense of margins. We think this strategy makes sense while China Mobile remains tied to its 3G TD-SCDMA network. However, with 4G likely coming in the next few months, this strategy may not continue to work. For now, though, we…
